Turing CEO Martin Shkreli, whose company jacked up drug price, is in custody after securities probe

December 17, 2015 1:55 PM

30 0

Martin Shkreli, the former hedge-fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is in custody following a securities probe.

Calls to an attorney that has represented Shkreli in the past were not immediately returned. His arrest was confirmed Thursday by FBI spokeswoman Kelly Langmesser.

Also read: FDA approves expanded use of AstraZeneca cancer drug

Read more

To category page